⏳ Fetching live dividend data...
Home › Calculator › NTEC Dividend Calculator 2026
Intec Pharma Ltd · NASDAQ
Price: $9.63 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in NTEC → $66.0K in 10 years · $945.81/month
Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd in March 2004. Intec Pharma Ltd was founded in 2000 and is based in Jerusalem, Israel.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NTEC position with:
Real after-tax yield depends on where you live and how you hold NTEC.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 20.77% | 17.97% | $2,077 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 17.65% | 14.85% | $1,765 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 16.62% | 13.82% | $1,662 / yr |
| 🇬🇧 UK ISA | 0% | 20.77% | 17.97% | $2,077 / yr |
| 🇬🇧 UK Taxable | 8.75% | 18.95% | 16.15% | $1,895 / yr |
| 🇨🇦 TFSA | 0% | 20.77% | 17.97% | $2,077 / yr |
| 🇨🇦 CA Taxable | 25% | 15.58% | 12.78% | $1,558 / yr |
| 🇦🇺 Super (pension) | 15% | 17.65% | 14.85% | $1,765 / yr |
| 🇦🇺 AU Taxable | 30% | 14.54% | 11.74% | $1,454 / yr |
| 🇩🇪 DE Taxable | 26.375% | 15.29% | 12.49% | $1,529 / yr |
| 🇫🇷 FR Taxable | 30% | 14.54% | 11.74% | $1,454 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
NTEC pays quarterly — 4 times per year. Next ex-div: TBD.
How NTEC compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NTEC sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2021-07-23 | 500 | $24.60 | $12.3K | ||
| Other | 2021-07-23 | 250 | $355.20 | $88.8K | ||
| Other | 2021-07-23 | 250 | $388.60 | $97.2K | ||
| Other | 2021-07-23 | 281 | $480.00 | $134.9K | ||
| Other | 2021-07-23 | 250 | $388.60 | $97.2K | ||
| Other | 2021-07-23 | 250 | $355.20 | $88.8K | ||
| Other | 2021-07-23 | 500 | $24.60 | $12.3K | ||
| Other | 2021-07-23 | 250 | $355.20 | $88.8K | ||
| Other | 2021-07-23 | 250 | $388.60 | $97.2K | ||
| Other | 2021-07-23 | 500 | $24.60 | $12.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NTEC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →